Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FAST kinase domain-containing protein 5, mitochondrial (FASTKD5), is a mitochondrial RNA-binding protein that plays a critical role in the post-transcriptional processing of specific mitochondrial mRNA precursors, particularly those that are not flanked by tRNA genes in polycistronic transcripts. FASTKD5 is a member of the FASTK protein family and localizes to mitochondrial RNA granules, facilitating the maturation of non-canonical precursor mRNAs such as those encoding CO1, CO3, and CYB. Its function is essential for proper mitochondrial translation, complex IV assembly, and oxidative phosphorylation. Loss of FASTKD5 leads to profound mitochondrial translation defects and impaired bioenergetics, highlighting its pivotal regulatory role in mitochondrial gene expression and cell viability. There are currently no known drugs directly targeting FASTKD5, and it is not recognized as a therapeutic target. Deficiency or malfunction may contribute to certain mitochondrial diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FAST kinase domain-containing protein 5, mitochondrial (FASTKD5).